This article examines the ongoing challenge of rising HIV infections in the United States and its implications for ending the epidemic. Despite over 40 years of scientific and medical advancements—including widespread access to antiretroviral therapy (ART), single-pill regimens, long-acting injectables, and pre-exposure prophylaxis (PrEP)—new HIV infections remain disproportionately high among Black and Latine communities.

This article provides a comprehensive overview of Doxycycline Post-Exposure Prophylaxis (Doxy-PEP), an antibiotic used to reduce the risk of bacterial sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis following condomless sex. It explains how Doxy-PEP works, the correct dosage and timing (200 mg within 24–72 hours after exposure), and who should or should not take it, including guidance for pregnant individuals. The article discusses potential side effects, interactions with other medications, and considerations regarding antibiotic resistance.

This article provides a comprehensive overview of hepatitis B (HBV) and its relationship to liver cancer and other potential health risks. Hepatitis B is a viral infection transmitted through infected blood and bodily fluids, which can lead to liver inflammation, fibrosis, cirrhosis, and ultimately liver cancer. The article emphasizes that HBV can be asymptomatic, making screening critical for early detection and prevention.

This long-term population study examines the real-world effectiveness of human papillomavirus (HPV) vaccines in preventing HPV infections among adolescent and young adult women, including those who remained unvaccinated. Conducted in Cincinnati from 2006 to 2023 and involving 2,335 participants aged 13–26, the research evaluated the impact of the 2-, 4-, and 9-valent HPV vaccines as community vaccination rates rose from 0% to 82% over 17 years.

This study describes the development and implementation of a comprehensive HIV co-testing initiative across Intermountain Health’s urgent care clinics and emergency departments. The program was designed to standardize HIV screening for patients undergoing evaluation for sexually transmitted infections, addressing historically low HIV testing rates in Utah. Key components included clinician and patient education, electronic health record alerts prompting HIV test orders when appropriate, and a structured link-to-care system to ensure rapid follow-up for newly diagnosed individuals.